Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock opened at $0.00 on Monday. The stock has a market cap of $2,964.00, a P/E ratio of 0.00 and a beta of 3.67. The firm has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.05. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.91.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.